No significant difference in OS was observed between cytoplasmic PPARγ-positive and -negative patients in BC with mild or increased peritumoral inflammation (Figure 11B,C, p = 0.280 and C, p = 0.225, respectively). This evidence concerns the gene PPARG and breast cancer.